1-Methyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol, 95.0%, 10g

Cyclohexane, min 99.5%, for synthesis, 2.5L, glass packaging

2-Aminomalonamide, 95.0%, 25g

(E)-Methyl 2-(2-(bromomethyl)phenyl)-3-methoxyacrylate, 95%, 250mg

Methyl 5-chloro-2-cyanobenzoate, 95.0%, 1g

4-Fluoro-1-methyl-2-(methylsulfonyl)benzene, 98%, 5g

(3E,5E)-1-ACRYLOYL-3,5-BIS(4-NITROBENZYLIDENE)PIPERIDIN-4-ONE, 95%, 5mg

N-[(1R,2R)-2-Amino-1,2-bis(4-methoxyphenyl)ethyl]4-methylbenzenesulfonamide, 97%, 5g

3-Bromo-5-hydroxybenzaldehyde, 98.0%, 25g

4-ALLYL-4-HYDROXYMETHYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 100mg

(R)-(+)-2-(DIPHENYLPHOSPHINO)-2'-METHOXY-1,1'-BINAPHTHYL, 98%, 100mg

Methyl 2-bromo-4-(bromomethyl)benzoate, 95.0%, 250mg

4-[{1-(tert-Butoxycarbonyl)piperidin-4-ylamino}methyl]benzoic acid, 95.0%, 1g